TTK and cervical carcinoma: Specific inhibitors of TTK were screened using high throughput in vitro kinase assays, yielding AZ3146, MPI-0479605 and Mps1-IN-1 in inhibiting proliferation of cervical carcinoma cell Hela and colon carcinoma cell HCT-116, respectively [12–14].